Sutimlimab Eases Fatigue and Anemia Symptoms, Trials Show

Sutimlimab Eases Fatigue and Anemia Symptoms, Trials Show

311858

Sutimlimab Eases Fatigue and Anemia Symptoms, Trials Show

Sutimlimab increased hemoglobin, lowered levels of red blood cell destruction markers, and eased fatigue and symptoms related to anemia in patients with cold agglutinin disease (CAD), according to a recent analysis of CADENZA. In addition, pooled data from CADENZA (NCT03347422) and CARDINAL (NCT03347396) — two Phase 3 clinical trials assessing the safety and efficacy of the medication in CAD patients — showed sutimlimab also led to improvements in physical and mental health scores related to…

You must be logged in to read/download the full post.